全球药物释放型球囊市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，药物释放型球囊市场规模将从 2025 年的 18.3 亿美元成长至 43.3 亿美元，2026 年至 2034 年的复合年增长率为 10.03%。

受心血管疾病盛行率上升和微创治疗方法需求成长的推动，全球药物释放型球囊（DEB）市场预计将显着成长。药物释放型球囊是一种用于血管成形术的专用医疗设备，可将治疗药物直接输送到动脉粥状硬化病变部位，从而降低再血管再阻塞的风险。随着医疗专业人员寻求治疗血管疾病的有效方案，药物释放型球囊的应用预计将大幅增加，进而推动该市场的创新和投资。

此外，药物洗脱球囊（DEB）技术和药物製剂的进步预计将进​​一步推动药物释放型球囊市场的发展。新型药物组合和球囊设计的研发，提高了DEB的疗效和安全性，从而改善了其在临床应用中的表现。此外，对病患疗效和医疗品质的日益重视，也推动了对能够提供更佳长期疗效的先进DEB解决方案的需求。随着製造商越来越认识到高品质药物释放型球囊在实现治疗目标方面的重要性，满足不同患者需求的创新解决方案的需求很可能会激增。

此外，对监管合规性和临床证据日益重视预计将塑造药物释放型球囊市场的未来。随着监管机构实施更严格的医疗设备指南并要求提供可靠的临床数据，符合这些标准的药物洗脱球囊的需求将持续成长。药物洗脱球囊製造商、医疗服务提供者和监管机构之间的合作对于推动这些进步并确保药物释放型球囊市场始终处于心血管治疗创新领域的前沿至关重要。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

第四章：全球药物释放型球囊市场：依产品类型划分

• 市场分析、洞察与预测
• 末梢用药物释放型球囊
• 冠状动脉药物释放型球囊
• 其他的

第五章：全球药物释放型球囊市场：依应用领域划分

• 市场分析、洞察与预测
• 周边动脉疾病
• 冠状动脉疾病
• 其他的

第六章 全球药物释放型球囊市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 专科诊所
• 其他的

第七章 全球药物释放型球囊市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Cook Medical
  • Biotronik
  • Abbott Laboratories
  • Terumo Corporation
  • Surmodics Inc
  • Eurocor GmbH
  • Meril Life Sciences Pvt. Ltd
  • Concept Medical Inc
  • MedAlliance SA
  • Biosensors International Group Ltd
  • Cardionovum GmbH
  • Acotec Scientific Co. Ltd

The Drug Eluting Balloon Market size is expected to reach USD 4.33 Billion in 2034 from USD 1.83 Billion (2025) growing at a CAGR of 10.03% during 2026-2034.

The global drug eluting balloon (DEB) market is set to experience substantial growth, driven by the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive treatment options. Drug eluting balloons are specialized medical devices used in angioplasty procedures to deliver therapeutic agents directly to the site of atherosclerotic lesions, reducing the risk of restenosis. As healthcare providers seek effective solutions for treating vascular diseases, the adoption of drug eluting balloons is expected to rise significantly, fostering innovation and investment in this market.

Moreover, advancements in DEB technology and drug formulations are anticipated to further boost the drug eluting balloon market. The development of new drug combinations and balloon designs that enhance the efficacy and safety of DEBs is improving their performance in clinical settings. Additionally, the growing emphasis on patient outcomes and quality of care is driving the demand for advanced DEB solutions that provide better long-term results. As manufacturers increasingly recognize the importance of high-quality drug eluting balloons in achieving therapeutic goals, the market is likely to witness a surge in demand for innovative solutions that cater to diverse patient needs.

In addition, the increasing focus on regulatory compliance and clinical evidence is expected to shape the future of the drug eluting balloon market. As regulatory bodies implement stricter guidelines for medical devices and require robust clinical data, the demand for DEBs that meet these standards will continue to rise. Collaborative efforts between DEB manufacturers, healthcare providers, and regulatory agencies will be essential in driving these advancements, ensuring that the drug eluting balloon market remains at the forefront of cardiovascular treatment innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Peripheral Drug Eluting Balloons
• Coronary Drug Eluting Balloons
• Others

By Application

• Peripheral Artery Disease
• Coronary Artery Disease
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

COMPANIES PROFILED

• Medtronic, Boston Scientific Corporation, B Braun Melsungen AG, Cook Medical, Biotronik, Abbott Laboratories, Terumo Corporation, Surmodics Inc, Eurocor GmbH, Meril Life Sciences Pvt Ltd, Concept Medical Inc, MedAlliance SA, Biosensors International Group Ltd, Cardionovum GmbH, Acotec Scientific Co Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG ELUTING BALLOON MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Peripheral Drug Eluting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Coronary Drug Eluting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG ELUTING BALLOON MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG ELUTING BALLOON MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG ELUTING BALLOON MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG ELUTING BALLOON INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 B. Braun Melsungen AG
  • 9.2.4 Cook Medical
  • 9.2.5 Biotronik
  • 9.2.6 Abbott Laboratories
  • 9.2.7 Terumo Corporation
  • 9.2.8 Surmodics Inc
  • 9.2.9 Eurocor GmbH
  • 9.2.10 Meril Life Sciences Pvt. Ltd
  • 9.2.11 Concept Medical Inc
  • 9.2.12 MedAlliance SA
  • 9.2.13 Biosensors International Group Ltd
  • 9.2.14 Cardionovum GmbH
  • 9.2.15 Acotec Scientific Co. Ltd